@FiercePharma: India's Sun Pharma beats on profits, with 31% revenue hike to about $550M. More | Follow @FiercePharma
@EricPFierce: U.S. arrests 2 Pakistani men for selling controlled substances via the Internet. Interpol tracks them to London. Report | Follow @EricPFierce
> Bayer's blood thinner Xarelto won Europe's blessing for a new indication in treating patients with acute coronary syndrome, a use the FDA has so far declined to approve. Report
> A hospital in Mumbai advised doctors that certain Ranbaxy medicines would not be available there and advised doctors not to prescribe them; company officials are reportedly negotiating with the facility. Report
> The tax debates in Ireland continue, this time with talk about two Abbott Laboratories ($ABT) subsidiaries that each reported profits topping €1 billion but paid no tax. Report
> India's Sun Pharmaceutical posted a 23.4% increase in quarterly profits on a 31% hike in sales to 30.71 billion rupees, or $549 million. Report
> Turkish officials aim to boost local drug production with proposed investments in medical research and development. Report
> An AstraZeneca ($AZN) unit will unload about 3.7 million shares of the company's Indian subsidiary to meet new securities regulations that set a minimum on public shareholding. Report
@FierceMedDev: Roche launches DNA kit amid applied science shake-up. Article | Follow @FierceMedDev
@DamianFierce: In case you missed it Monday, Valeant is buying Bausch + Lomb for $8.7B. Report | Follow @DamianFierce
> Medical device firms still passing tax on to hospitals, group says. Item
> Sluggish FDA device approvals frustrate cardiologists. Report
> Paris, je stent: Fierce's 2013 EuroPCR coverage. More
> FDA sticks 'deadly' tag on Cook's stent recall. News
Biotech News
@FierceBiotech: Trending this weekend: Top 10 Biotech CEO Pay Packages of 2012. Feature | Follow @FierceBiotech
@JohnCFierce: From earlier today: AstraZeneca scoops up PhIII cardio drug in $443M Omthera buyout (did AZ pay too much?) Story | Follow @JohnCFierce
> Are biotech IPOs already getting too hot to handle? More
> Biotech gets $12M to work on amped-up herbal anti-inflammatory. Item
> Pharmaxis slashes staff after FDA red-flags cystic fibrosis treatment. Article
> Alexion snags latest 'breakthrough' coup with PhIII rare-disease drug. News
Pharma News
@FiercePharma: India's Sun Pharma beats on profits, with 31% revenue hike to about $550M. More | Follow @FiercePharma
@EricPFierce: U.S. arrests 2 Pakistani men for selling controlled substances via the Internet. Interpol tracks them to London. Report | Follow @EricPFierce
> Feds subpoena Forest Labs in Tudorza Pressair investigation. Story
> Drugmakers to reap $115B in sales as Obamacare rolls on, study finds. Report
> ISTA excluded from Medicare in $33.5M off-label settlement. Article
Pharma Manufacturing News
> India takes another step to meet looming EU API rules. Story
> FDA tracking down new outbreak tied to compounded drug. More
> U.S. holds two Pakistani men for Internet sales of controlled substances. Report
> Indian regulators unsure how to react to USFDA actions. Article
CRO News
> Parexel expands eClinical presence in China. Article
> India amps up clinical trial consent regulations. Report
> Corgenix inks cancer deal with Lilly. More
> Nordion sells off drug unit for $200M, focuses on contracting. Story
Biotech IT News
> Boehringer VP impressed by wireless pill bottle. Item
> Treato sees success for Biogen in social media buzz. Article
> Genentech asks iPad gamers to save San Fran from mutant cheese. More
> Chinese trial data hackers reportedly active again. Report
Biotech Research News
@EmilyMFierce: Universal flu vaccine effective in preclinical studies. More | Follow @EmilyMFierce
> Stem cell cloning study contained errors. Story
> Stabilizing a gene reverses schizophrenia in mice. Report
> New study refutes Targretin claim for treatment of Alzheimer's. Article
And Finally... Does the FDA need to remove some roadblocks to new sunblock ingredients? Report